Efficacy of clobazam as add-on therapy in brain tumor-related epilepsy.

Nupur BrahmbhattRoger StuppOmar BusharaElizabeth BachmanStephan U SchueleJessica W Templer

Published in: Journal of neuro-oncology (2021)

Clobazam is an effective agent to use as add-on AED in TRE, with 94% of patients showing a significant response within 6 months. Furthermore, the addition of clobazam may yield a reduction in polypharmacy, as concomitant AEDs can be reduced and potentially withdrawn.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
patient reported outcomes
mesenchymal stem cells
bone marrow